Literature DB >> 518220

Role of renin classification for diuretic treatment of black hypertensive patients.

O B Holland, C Gomez-Sanchez, C Fairchild, N M Kaplan.   

Abstract

Previous studies in white and mixed-race hypertensive patient populations have generally found patients with low renin activity more responsive to diuretic therapy than patients with normal renin activity. Twenty-nine black patients (26 women and three men) with placebo diastolic blood pressure of 90 to 115 mm Hg were treated with spironolactone (100 to 400 mg/day) and hydrochlorothiazide (100/mg/day). Renin status was categorized by (1) the intravenous furosemide test, (2) ambulation during placebo, and (3) ambulation during spironolactone and hydrochlorothiazide treatment. Only seven patients were categorized identically with all methods. No method identified a low renin subgroup that was more responsive to either spironolactone or hydrochlorothiazide. Diastolic blood pressure fall with hydrochlorothiazide (18 mm Hg) and 400 mg/day of spironolactone (15 mm Hg) was similar. Thus, since black women with both low and normal renin activity are quite responsive to diuretics, renin classification to guide initial antihypertensive selection is not warranted.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518220

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Blood pressure-lowering efficacy of loop diuretics for primary hypertension.

Authors:  Vijaya M Musini; Pouria Rezapour; James M Wright; Ken Bassett; Ciprian D Jauca
Journal:  Cochrane Database Syst Rev       Date:  2015-05-22

2.  Black/white differences in response to antihypertensive therapy.

Authors:  B J Materson
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

Review 3.  Racial differences in antihypertensive therapy: evidence and implications.

Authors:  M H Weinberger
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 4.  The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.

Authors:  J R M'Buyamba-Kabangu; M Tambwe
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

5.  Aldosterone suppression with dopamine infusion in low-renin hypertension.

Authors:  O B Holland; C Thomas; H Brown; D Schindewolf; Y Hillier; C Gomez-Sanchez
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Beta blockers, hypertension, and blacks--is the answer really in?

Authors:  R V Veiga; R E Taylor
Journal:  J Natl Med Assoc       Date:  1986-09       Impact factor: 1.798

Review 7.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.